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Abstract
Background—During the past decade, investigators have reported transmissions of blood-borne 
pathogens (BBPs) in dental settings. In this article, the authors describe these transmissions and 
examine the lapses in infection prevention on the basis of available information.
Methods—The authors reviewed the literature from 2003 through 2015 to identify reports of the 
transmission of BBPs in dental settings and related lapses in infection prevention efforts, as well as 
to identify reports of known or suspected health care–associated BBP infections submitted by state 
health departments to the Centers for Disease Control and Prevention.
Results—The authors identified 3 published reports whose investigators described the 
transmission of hepatitis B virus and hepatitis C virus. In 2 of these reports, the investigators 
described single-transmission events (from 1 patient to another) in outpatient oral surgery 
practices. The authors of the third report described the possible transmission of hepatitis B virus to 
3 patients and 2 dental health care personnel in a large temporary dental clinic. The authors 
identified lapses in infection prevention practices that occurred during 2 of the investigations; 
however, the investigators were not always able to link a specific lapse to a transmission event. 
Examples of lapses included the failure to heat-sterilize handpieces between patients, a lack of 
training for volunteers on BBPs, and the use of a combination of unsafe injection practices.
Conclusions—The authors found that reports describing the transmission of BBPs in dental 
settings since 2003 were rare. Failure to adhere to Centers for Disease Control and Prevention 
recommendations for infection control in dental settings likely led to disease transmission in these 
cases.
Practical Implications—The existence of these reports emphasizes the need to improve dental 
health care personnel's understanding of the basic principles and implementation of standard 
precautions through the use of checklists, policies, and practices.
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Transmissions of blood-borne pathogens (BBPs) in a dental health care setting have rarely 
been reported, particularly since routine hepatitis B virus (HBV) vaccination of dental health 
care personnel (DHCP) and universal precautions were recommended (1982 and 1987, 
respectively).1-5 BBPs of primary concern include HBV, hepatitis C virus (HCV), and 
human immunodeficiency virus (HIV). In 1996, the Centers for Disease Control and 
Prevention (CDC) expanded the concept of universal precautions and changed the term to 
“standard precautions.”6 Standard precautions integrate and expand the elements of 
universal precautions into a standard of care designed to protect health care personnel (HCP) 
and patients from pathogens that can be spread by means of blood or any other body fluid, 
excretion, or secretion, except sweat and tears. The Occupational Safety and Health 
Administration standard regarding BBPs focuses on protecting HCP from BBPs and retains 
the term “universal precautions.”7
We identified 3 reports describing transmissions of HBV and HCV in dental settings,8-10 all 
of which were published after the release of the CDC's Guidelines for Infection Control in 
Dental Health-Care Settings—2003.3 We examined these reports and noted the lapses in 
infection prevention on the basis of the available information. We considered whether the 
transmissions had resulted from the failure to adequately implement existing CDC 
recommendations for infection prevention and control and whether additional 
recommendations were needed.
METHODS
In 2012, the authors (J.L.C., S.K.G., J.A.H.) began a literature review to identify published 
reports of confirmed transmissions of BBPs in US dental settings since 2003. We defined 
transmissions as those situations for which the results of the epidemiologic investigation 
confirmed or identified a strong epidemiologic and molecular link between cases; we 
defined cases as people with acute viral hepatitis who visited the same dental clinic as other 
people who had acute or chronic viral hepatitis infection.11,12 We conducted literature 
searches using Ovid MEDLINE, Web of Science, Cochrane Library, and the National 
Guideline Clearinghouse. Search terms included “disease transmission,” “surveillance,” 
“dental,” “dentistry,” “oral health,” “infection control,” “infection prevention,” “blood-borne 
pathogens,” “hepatitis B virus” or “HBV,” “hepatitis C virus” or “HCV,” “human 
immunodeficiency virus” or “HIV,” “occupational exposure,” “breaches,” “health care-
associated infections” or “HAIs,” and “compliance.” We limited searches to articles 
published in English from January 2003 through November 2015, and we excluded 
editorials, expert opinions, and general reviews.
In addition, we reviewed published summaries from CDC's Division of Viral Hepatitis, 
which is part of the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB 
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Prevention, of suspected health care–associated hepatitis transmissions reported by state and 
local health departments from 1998 to 2014.11,12 HBV and HCV infections are reportable 
conditions in all states. Surveil-lance case report forms for viral hepatitis infections request 
information about potential behavioral risks, such as sexual contact and injection drug use, a 
history of working in a health care setting, and a history of receiving medical and dental 
treatment during the likely exposure period. State and local health departments investigate 
patients who do not report behavioral risk factors to determine potential sources of 
transmission. Although it is not mandatory for health departments to report suspected health 
care–associated hepatitis cases to the CDC, health departments can request that the CDC 
provide consultation and laboratory assistance to complete these investigations.
RESULTS
By searching the literature and reviewing reports to the CDC of transmission events from 
2003 to 2015, we identified 3 episodes of BBP transmission in US dental settings (Table 
18-10). In 2 episodes,8,10 investigators confirmed a single instance of patient-to-patient 
transmission of either HBV or HCV. Both single-transmission episodes of BBPs occurred in 
outpatient oral surgery practices. In a third episode,9 investigators identified acute HBV 
infection in 3 patients and 2 DHCP who were volunteers and not involved directly in the 
delivery of clinical care (Box 13). We did not identify any transmissions of HIV among 
dental patients or DHCP during our search.
In 2002, a state health department conducted an epidemiologic investigation of a person who 
had an acute HBV infection (Table 1).8 This index patient (that is, the first case or instance 
of a patient who came to the attention of health authorities) had no identified risk of 
developing infection, but the patient reported having recently had oral surgery involving 
intravenous (IV) sedation and undergone the extraction of 7 teeth. A retrospective 
investigation of the treating oral surgery practice revealed that another patient (the source 
patient), who had been seen earlier on the same day as the index patient, was listed on the 
state's reportable disease registry for HBV. Documentation showed that at the time the 
source patient had 3 teeth extracted under IV general anesthesia, she also had chronic 
hepatitis B and had tested positive for hepatitis e antigen with a high viral load. The findings 
of molecular genetic testing confirmed the transmission of HBV between this source patient 
and the index patient. During the investigation, office staff members reported that they had 
followed standard infection prevention and control practices. All staff members had been 
vaccinated, and none of them had HBV. The investigators only could speculate that the virus 
had been spread via an environmental surface that remained contaminated with blood, 
despite the staff members’ reportedly good cleaning practices. Furthermore, the fact that a 
substantial prevalence of previous vaccination (64%) among the patients who were treated 
after the source patient may have limited the potential for additional HBV transmissions.
In 2013, another single transmission of a BBP—this time involving HCV—from 1 oral 
surgery patient to another occurred10 (Table 1). The case was initially reported to state 
public health officials as a potential health care–associated HCV infection when a regular 
blood donor screened positive for HCV infection during a routine blood donation. All of the 
patient's previous blood donations, including 1 that had occurred in April 2012, had tested 
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negative for HCV. The patient did not report having any typical risk factors for HCV 
infection, but the patient had undergone oral surgical procedures during multiple dental 
appointments at a single dental practice within the 3 months before testing positive for HCV. 
Investigators found multiple lapses of infection prevention and control practices, including 
but not limited to having dental assistants on staff who did not have appropriate certification 
and who determined dosage and administered IV sedation medication, improper dating and 
storage of multidose medication vials, use of single-dose medication vials for more than 1 
patient, and a lack of autoclave monitoring and maintenance. Molecular testing conducted 
by CDC staff members compared HCV specimens from the index patient with another clinic 
patient who was known to be infected with HCV and who had undergone an oral surgical 
procedure on the same day as the index patient. These test results showed close molecular 
identity, which indicated a likely transmission between the 2 patients. Although the 
investigators identified multiple lapses in infection prevention practices, they concluded that 
it was possible that DHCP may have reused needles, syringes, or both to enter medication 
vials and then subsequently used one of those medication vials when treating another 
patient.10 This unsafe injection practice, which contaminates the contents of the medication 
vial, has been associated with the transmission of BBPs in a variety of health care 
settings.13,14 The investigators did not identify any other cases of blood-borne infections that 
could be linked definitively to transmission among patients at this oral surgery clinic.
In 2009, investigators from the local and state health departments identified an outbreak of 5 
acute HBV infections at a 2-day portable dental clinic9 (Table 1). Set up in a gymnasium, 
the dental clinic was staffed by 750 volunteers, and more than 1,100 adults received dental 
treatment. The 5 acute HBV infections included 3 patients and 2 DHCP who were not 
involved directly with patient care. All 3 patients had undergone extractions; 1 of the 
patients also had received restorations and another patient also received a dental prophylaxis. 
None of the 3 patients shared a treatment provider. One of the cases involved a member of 
the DHCP team at the clinic whose role was to maintain the dental equipment. The DHCP 
reported that, while wearing gloves, he had handled a blood-contaminated air compressor. 
He also reported having had frequent episodes of nose-blowing and had wiped sweat from 
his brow without removing his gloves. He also reported that he had worked at a similar 
clinic 2 weeks previously. When working at that clinic, he did not wear a mask or protective 
eyewear, and, while handling a full suction container, he had been splashed in the face by 
blood-contaminated saliva. The second case involving DHCP was a person who had directed 
patients from triage to the treatment waiting area. This person did not report having had any 
contact with blood. None of the 5 people who had acute HBV infections had reported having 
any behavioral risk factors for HBV, such as a recent history of injection drug use or 
multiple sex partners. By reviewing the state's HBV registry, the case investigators revealed 
3 possible source patients (that is, patients who had positive serologic tests for hepatitis B 
surface antigens before they had visited the portable dental clinic). Serologic specimens 
were not available from these patients to conduct viral sequencing or to make comparisons 
with the outbreak cases.
The results of the investigation9 revealed several breaches of infection prevention practices 
that could have resulted in the exposure of patients, staff, and environmental surfaces to 
HBV and other BBPs. For example, reports indicated that the outer surfaces of dental 
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handpieces had been cleaned with disinfectant wipes but were returned to service without 
being heat-sterilized before being used on other patients, that used instruments had been 
sterilized unwrapped, and that some patients had been allowed to carry their partially used 
anesthetic cartridges in the metal dental cartridge syringes on a tray to other stations if the 
anesthetic might have been needed for later reuse. Patient treatment chairs and portable 
dental units were in close proximity, and DHCP performed oral surgical procedures in 
treatment areas lacking physical barriers, such as curtains.
In addition, the results of the investigation9 revealed that volunteers who were not involved 
in patient care did not receive training about BBPs, and no one had verified their histories of 
having received the hepatitis B vaccination, even though the volunteers could potentially be 
exposed to blood. It was assumed that the licensed dentists and dental students who 
volunteered already received the HBV vaccination and training in preventing the 
transmission of BBPs. The clinic did have a policy for needlestick reporting and follow-up; 
however, written policies including training in and oversight for infection prevention and 
control were lacking. Written information about individual patient procedures and providers 
was limited. Despite the identification of breaches related to infection prevention and control 
during the clinic, it was not possible to retrospectively link specific practices to the 
transmission of HBV in this outbreak. Laboratory results from the patients’ HBV gene 
sequences showed that all were genotype D and that a partial gene sequence was identical in 
all cases; this finding provides limited evidence that these 5 outbreak cases could have been 
exposed to blood from a common source.
DISCUSSION
Infection prevention recommendations are designed to prevent or reduce the potential for 
disease transmission from patient to DHCP, from DHCP to patient, and from patient to 
patient. Patient-to-patient transmission of BBP can occur when lapses in basic infection 
prevention practices allow patients who are infected with HBV or HCV to serve as an 
indirect source of pathogens for disease transmission to other patients. For example, in a 
dental setting, DHCP should appropriately clean, disinfect, or heat-sterilize instruments and 
equipment before using them on another patient.3,21 In addition, DHCP should barrier-
protect or clean and disinfect environmental surfaces, including the light handle, chair 
controls, computer mouse, or keyboard, between patients.3,21 Paying strict attention to 
aseptic technique when handling and administering parenteral medications, such as IV or 
intramuscular injections, can prevent the contamination of supplies used for injections, 
including medication vials, containers, needles, syringes, and IV tubing.3,15 Finally, because 
contaminated hands can cause health care–associated infections (HAIs), proper use of gloves 
and performing correct hand hygiene is critical.3,16,21
HBV and HCV transmission as a result of unsafe injection practices is well documented in 
US health care settings.11,12,17-19 As a result of these transmissions, recommendations for 
safe injection practices are now basic elements of standard precautions15,20 (Box 221). 
Investigators of the 2013 event concluded that the dental patient-to-patient transmission of 
HCV likely was caused by DHCP reentering medication vials with a syringe that already 
had been used for a patient who had a chronic HCV infection and then using the contents of 
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those vials for an injection in another patient.10 CDC recommends using single-dose 
medication vials whenever possible; if HCP must use multidose medication vials, they 
should dedicate the use of the vials to a single patient whenever possible. HCP should enter 
medication containers (single-dose and multidose medication vials, ampules, and bags) with 
a new needle and a new syringe, even when obtaining additional doses for the same patient. 
In addition, if HCP bring a multidose medication vial into an immediate patient treatment 
area, they should dedicate the vial for single-patient use and discard it immediately after 
use.15,20,22 CDC recommendations for safe injection practices (Box 221) apply not only 
when DHCP use parenteral medications combined with fluid infusion systems, such as for 
patients undergoing conscious sedation, but also when DHCP administer local anesthetic, 
during which they should use needles and cartridges containing local anesthetics for 1 
patient only and ensure that the dental cartridge syringe is cleaned and heat-sterilized 
between patients.3
HBV and HCV can persist on environmental surfaces and devices contaminated with blood. 
HBV is a hardy virus that has been demonstrated to survive in dried blood at room 
temperature on environmental surfaces for at least 1 week.23 In studies related to infectivity, 
the investigators have found that HCV can survive in the environment for up to 6 weeks on 
dry surfaces,24,25 although most HCV transmissions occur through percutaneous 
exposure.11,12 Strict adherence to CDC infection prevention recommendations for cleaning 
and disinfecting environmental surfaces and for packaging and heat-sterilizing contaminated 
instruments is critical in preventing the transmission of BBPs.26,27
In this review, we described 3 events involving the transmission of BBPs that occurred in the 
United States between 2001 and 2013.8-10 To put these events in context, we offer some 
historical comparisons of reported transmissions of BBPs in dental settings and the 
implementation of infection prevention recommendations. Before 1987, 9 outbreaks of HBV 
occurred in dental settings (general practice and oral surgery); the number of patients 
infected with hepatitis ranged from 3 patients in 1 outbreak to 55 patients in another.28 In 
each practice, the dentist or oral surgeon also was infected. In addition, the results of 
serologic surveys indicated that there were a number of asymptomatic cases, suggesting that 
more transmissions had occurred in some of these outbreaks than had been reported.28 To 
our knowledge, since 1987, there have been no transmissions of HBV or HCV in dental 
settings that involved an infected dentist or oral surgeon.
The hepatitis B vaccine became commercially available in 1982. Between 1983 and 1992, 
there was a 74% increase (from 22% to 85%) in the frequency of self-reported vaccination 
among US dentists participating in health screenings sponsored by the American Dental 
Association (ADA).29 Serologic evidence of past HBV infection among dentists declined 
from prevaccine levels of 14% in 1972 to 9% in 1992, likely reflecting increased 
immunization and use of standard precautions.29 From 1993 to 2007, levels of HBV 
infection among dentists remained relatively unchanged (Steven Gruninger, MS, senior 
research fellow, Research and Laboratories, Science Institute, American Dental Association, 
Chicago, IL, written communication, September 2014).
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The average (standard deviation) prevalence of HCV antibodies among US dentists 
participating in ADA health screenings from 2000 to 2005 (0.47% [0.15]) remained well 
below the level of the general population (1.3-1.6%), suggesting that dentists in the United 
States have a low occupational risk of developing HCV infection.30 In our review, we found 
no evidence of transmission of a BBP, including HCV, between an infected dentist or oral 
surgeon and a patient.
Documented, occupationally acquired HIV infection among HCP is rare in the United 
States, with few confirmed cases since the late 1990s. Transmission of HIV to 6 patients of a 
dentist with AIDS remains the only reported transmission of HIV in a dental setting.31,32
Transmission of BBPs is usually of greatest concern to DHCP because of their frequent 
direct or indirect contact with blood or blood-contaminated saliva. Other modes of 
transmission, such as inhalation of infectious microorganisms, also can result in HAIs. For 
example, separate episodes of transmission of Legionella infection and tuberculosis (TB), 
respectively, also were reported from 2003 to 2015.33,34 In 2011, an 82-year-old woman in 
Italy was diagnosed with Legionnaires’ disease, caused by Legionella pneumophila, and 
died 2 days later.33 The patient's only known risk of exposure for Legionella infection 
consisted of attending 2 dental appointments. All isolates obtained from the woman's 
bronchial aspirate were genetically identical to those obtained from dental unit waterline 
samples in her dentist's office. This incident reinforces the need to follow CDC 
recommendations for dental water quality.3,21
In 2010, investigators found that a dental hygienist who developed active pulmonary TB 
likely transmitted Mycobacterium tuberculosis to another DHCP who worked in the same 
practice location.34 The newly hired hygienist worked for several months in the dental 
practice while she was infectious because her TB symptoms originally were misdiagnosed. 
This report highlights the importance of implementing a written TB infection prevention and 
control plan that ensures baseline screening of new hires for active or latent TB that uses a 2-
step tuberculin skin test or a single blood assay for M. tuberculosis.3,35,36 In addition, DHCP 
should be trained to recognize the signs and symptoms suggestive of active TB disease.36
Although the transmissions of HBV and HCV described in this report could not be 
definitively linked with a specific breach of infection prevention and control practices, 
investigators of HAIs that have occurred in other medical settings have determined that 
HAIs were caused by the failure of HCP to consistently practice recommended infection 
prevention measures and to sufficiently integrate these measures into the day-to-day 
management of program areas.15 It is reasonable to assume that HAIs found in dental 
settings may be caused by similar lapses in compliance. In dental and medical settings, 
noncompliance with established guidelines has led not only to HAIs but also to burdens on 
resources at the state and local levels, such as the use of dedicated personnel, investigation 
costs, patient notification, and testing of potentially exposed patients for BBP infection.9,37
Our findings emphasize the importance that all DHCP, including those not involved directly 
in patient care but who may be exposed to infectious materials and those who use portable 
dental equipment, should adhere to recommended infection prevention practices. Adherence 
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involves providing operational oversight of infection prevention practices by an infection 
prevention coordinator, having written infection prevention policies and procedures, training 
DHCP in procedures that are designed to prevent BBP transmission and infection and that 
are appropriate for assigned duties, ensuring that all staff members who may come into 
contact with blood or body fluids have received HBV vaccination, and emphasizing the use 
of standard precautions as the foundation for a successful infection prevention 
program.3,7,9,15,38 Ongoing monitoring and routine evaluation of the infection prevention 
and control program are critical components for assessing compliance with recommended 
practices. Continuous review of the goals, activities, and practice policies should be followed 
by improvement activities that are realistic in expectation and, above all, effective. Table 23 
provides examples of methods for evaluating infection prevention and control programs.
Infection prevention recommendations should be available and easily understandable so that 
all DHCP can routinely implement the recommendations. To accomplish these goals, CDC 
has developed the Summary of Infection Prevention Practices in Dental Settings: Basic 
Expectations for Safe Care.21 This publication reflects existing evidence-based 
recommendations presented in CDC's Guidelines for Infection Control in Dental Health-
Care Settings—20033 and other selected CDC recommendations published since 
2003.15,27,39-44 It also emphasizes the elements of standard precautions and the basic 
infection prevention expectations for safe care in dental settings; this publication is meant to 
supplement existing recommendations, not replace them. It includes a companion checklist 
to be used in dental practice settings to assess infection prevention policies and procedures 
and the adequacy of their supplies for adhering to standard precautions. Users can modify 
this checklist to reflect individual practice policies and procedures. In addition, infection 
control coordinators can use the checklist to periodically evaluate compliance with correct 
infection prevention practices by means of observing DHCP when they are performing their 
duties. We anticipate that the Summary of Infection Prevention Practices in Dental Settings: 
Basic Expectations for Safe Care and checklist can supplement existing infection prevention 
guidelines from the CDC, provide the basis for training and educating DHCP, and ultimately 
ensure the safety of both dental patients and DHCP.
Limitations
The transmissions of BBPs that we summarized in this review may be an underestimate of 
the burden of infections resulting from lapses in infection control in dental settings. For 
example, some investigators may not have reported or linked transmissions of BBP in dental 
settings with dental treatment because of the long incubation period (up to 6 months) for 
HBV and HCV,23-25 the asymptomatic course of acute infection for viral hepatitis and 
sometimes for HIV infection,45 and the limited resources in state and local health 
departments to follow up on viral hepatitis cases that involved no identified risks or that 
lacked data on risk factors or health care visits.45,46 Even if a patient becomes symptomatic, 
the HCP might not suspect that the patient has a BBP infection, or if the patient has received 
a diagnosis, the HCP might not have reported the patient's infection to the health 
department.45
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The results of our review of reported transmissions of BBPs since 2003 indicate that the 
transmission of BBPs in US dental settings is infrequent. This finding emphasizes the 
overall importance of adhering to dental infection prevention recommendations, including 
standard precautions, to prevent BBP transmission and the dramatic effects of vaccination 
against occupational HBV infection. The CDC Guidelines for Infection Control in Dental 
Health-Care Settings—20033 remains the standard of care for the profession. Failure among 
DHCP to adhere to CDC infection prevention recommendations likely led to the disease 
transmissions identified in these reports. These transmissions highlight the need for 
improved understanding of the primary principles of infection prevention and control as well 
as the implementation of standard precautions among DHCP, including those who are not 
involved directly in patient care activities.
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 include dentists, dental hygienists, dental assistants, dental laboratory technicians (in-office and 
commercial), students and trainees, contract personnel, and other persons not directly involved in patient care 
but potentially exposed to infectious agents (e.g., administrative, clerical, housekeeping, maintenance or 
volunteer personnel).”
*
Source: Kohn and colleagues.3
†
DHCP: Dental health care personnel.
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Safe injection practices for dental health care 
settings
*
- Prepare injections using aseptic technique in a clean area.
- Disinfect the rubber septum on a medication vial with alcohol before piercing.
- Do not use needles or syringes
†
 for more than 1 patient (this includes manufactured prefilled syringes and 
other devices such as insulin pens).
- Enter medication containers (single-dose and multidose vials, ampules, and bags) with a new needle and new 
syringe, even when obtaining additional doses for the same patient.
- Use single-dose vials for parenteral medications when possible.
- Do not use single-dose medication vials, ampules, and bags or bottles of IV
‡
 solution for more than 1 patient.
- Do not combine the leftover contents of single-dose vials for later use.
- Apply the following guidelines if using multidose vials:
    ■ Dedicate multidose vials to a single patient whenever possible.
    ■ If multidose vials will be used for more than 1 patient, restrict the multidose vial to a centralized 
medication area and do not allow it to enter the immediate patient treatment area (for example, dental 
operatory) to prevent inadvertent contamination.
    ■ If a multidose vial enters the immediate patient treatment area, ensure that it is dedicated for single-patient 
use and discarded immediately after use.
    ■ Date multidose vials when first opened, and discard the vial within 28 days, unless the manufacturer 
specifies a shorter or longer date for an opened vial.
- Do not use fluid infusion or administration sets (for example, IV bags, tubings, and connections) for more 
than 1 patient.
*
Modified from Centers for Disease Control and Prevention.21
†
A note about administering local dental anesthetic: When dental health care personnel use a dental cartridge 
syringe to administer local anesthetic, they should not use the needle or the anesthetic cartridge for more than 1 
patient. They should ensure that the dental cartridge syringe is cleaned appropriately and heat-sterilized before 
using it with another patient.
‡
IV: Intravenous.
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TABLE 2
Examples of methods for evaluating infection prevention programs
*
PROGRAM ELEMENT EVALUATION ACTIVITY
Appropriate Immunizations of DHCP
† Conduct an annual review of individual personnel records to ensure up-to-date 
immunizations.
Education and Training Conduct an annual review to ensure that all DHCP received training on initial 
employment, when new tasks or procedures affected the employee's occupational 
exposure, and, at a minimum, annually.
Assessment of Occupational Exposures to Infectious 
Agents
Report occupational exposures to infectious agents. Document the steps that 
occurred around the exposure and plan how such exposures can be prevented in 
the future.
Comprehensive Postexposure Management and 
Medical Follow-up Program After Occupational 
Exposures to Infectious Agents
Ensure that postexposure management plan is clear, complete, and available at all 
times to all DHCP. All staff members should understand the plan, which should 
include toll-free phone numbers that provide access to additional information.
Adherence to Hand Hygiene Before and After Patient 
Care
Observe and document circumstances of appropriate or inappropriate 
handwashing. Review findings in a staff meeting.
Proper Use of Personal Protective Equipment to 
Prevent Occupational Exposures to Infectious Agents
Observe and document the use of barrier precautions and careful handling of sharp 
objects. Review findings in a staff meeting.
Routine and Appropriate Sterilization of Instruments 
Using a Biological Monitoring System
Monitor log records of cycle and temperature strip with each sterilization load, 
chemical indicators, and examine results of weekly biological monitoring. Take 
appropriate action when failure of sterilization process is noted.
Evaluation and Implementation of Safer Medical 
Devices
Conduct an annual review of the exposure prevention and control plan and 
consider new developments in safer medical devices.
Compliance of Water in Routine Dental Procedures 
With Current Environmental Protection Agency 
Drinking Water Standards (Fewer Than 500 Colony-
Forming Units of Heterotrophic Water Bacteria)
Monitor dental water quality as recommended by the equipment manufacturer, 
using commercial self-contained test kits or commercial water testing laboratories.
Proper Handling and Disposal of Medical Waste Observe the safe disposal of medical waste and take measures if hazardous 
situations occur.
Health Care–Associated Infection Assess the unscheduled return of patients after procedures and evaluate them for 
an infectious process. A trend may require formal evaluation.
*
Source: Kohn and colleagues.3 For a complete discussion of program evaluation, refer to this source.
†
DHCP: Dental health care personnel.
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